Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Familial risks of ovarian cancer by age at diagnosis, proband type and histology.

Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K.

PLoS One. 2018 Oct 3;13(10):e0205000. doi: 10.1371/journal.pone.0205000. eCollection 2018.

2.

Prostate cancer survivors: Risk and mortality in second primary cancers.

Chattopadhyay S, Zheng G, Hemminki O, Försti A, Sundquist K, Hemminki K.

Cancer Med. 2018 Oct 1. doi: 10.1002/cam4.1764. [Epub ahead of print]

3.

Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.

Chattopadhyay S, Sud A, Zheng G, Yu H, Sundquist K, Sundquist J, Försti A, Houlston R, Hemminki A, Hemminki K.

Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31801. [Epub ahead of print]

PMID:
30238973
4.

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.

Went M, Sud A, Försti A, Halvarsson BM, Weinhold N, Kimber S, van Duin M, Thorleifsson G, Holroyd A, Johnson DC, Li N, Orlando G, Law PJ, Ali M, Chen B, Mitchell JS, Gudbjartsson DF, Kuiper R, Stephens OW, Bertsch U, Broderick P, Campo C, Bandapalli OR, Einsele H, Gregory WA, Gullberg U, Hillengass J, Hoffmann P, Jackson GH, Jöckel KH, Johnsson E, Kristinsson SY, Mellqvist UH, Nahi H, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N, Nickel J, Nöthen MM, Rafnar T, Ross FM, da Silva Filho MI, Thomsen H, Turesson I, Vangsted A, Andersen NF, Waage A, Walker BA, Wihlborg AK, Broyl A, Davies FE, Thorsteinsdottir U, Langer C, Hansson M, Goldschmidt H, Kaiser M, Sonneveld P, Stefansson K, Morgan GJ, Hemminki K, Nilsson B, Houlston RS; PRACTICAL consortium.

Nat Commun. 2018 Sep 13;9(1):3707. doi: 10.1038/s41467-018-04989-w.

5.

Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.

Sud A, Thomsen H, Orlando G, Försti A, Law PJ, Broderick P, Cooke R, Hariri F, Pastinen T, Easton DF, Pharoah PDP, Dunning AM, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N, Campa D, Hoffmann P, Nöthen MM, Jöckel KH, von Strandmann EP, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS.

Blood. 2018 Sep 7. pii: blood-2018-06-855296. doi: 10.1182/blood-2018-06-855296. [Epub ahead of print]

PMID:
30194254
6.

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.

Chattopadhyay S, Hemminki O, Försti A, Sundquist K, Sundquist J, Hemminki K.

Prostate Cancer Prostatic Dis. 2018 Sep 5. doi: 10.1038/s41391-018-0089-y. [Epub ahead of print]

PMID:
30185889
7.

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.

Chattopadhyay S, Thomsen H, da Silva Filho MI, Weinhold N, Hoffmann P, Nöthen MM, Marina A, Jöckel KH, Schmidt B, Pechlivanis S, Langer C, Goldschmidt H, Hemminki K, Försti A.

Mol Med. 2018 Jun 11;24(1):30. doi: 10.1186/s10020-018-0031-8.

8.

Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients.

Mahmoudpour SH, Bandapalli OR, da Silva Filho MI, Campo C, Hemminki K, Goldschmidt H, Merz M, Försti A.

BMC Cancer. 2018 Aug 15;18(1):820. doi: 10.1186/s12885-018-4728-4.

9.

Multiple myeloma: family history and mortality in second primary cancers.

Chattopadhyay S, Yu H, Sud A, Sundquist J, Försti A, Hemminki A, Hemminki K.

Blood Cancer J. 2018 Aug 7;8(8):75. doi: 10.1038/s41408-018-0108-1. No abstract available.

10.

Correction: Inherited variants in genes somatically mutated in thyroid cancer.

Campo C, Köhler A, Figlioli G, Elisei R, Romei C, Cipollini M, Bambi F, Hemminki K, Gemignani F, Landi S, Försti A.

PLoS One. 2018 Aug 7;13(8):e0202208. doi: 10.1371/journal.pone.0202208. eCollection 2018.

11.

Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden.

Chattopadhyay S, Zheng G, Sud A, Yu H, Sundquist K, Sundquist J, Försti A, Hemminki A, Houlston R, Hemminki K.

Lancet Haematol. 2018 Aug;5(8):e368-e377. doi: 10.1016/S2352-3026(18)30108-X.

PMID:
30075833
12.

Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.

Kumar A, Bandapalli OR, Paramasivam N, Giangiobbe S, Diquigiovanni C, Bonora E, Eils R, Schlesner M, Hemminki K, Försti A.

Sci Rep. 2018 Aug 2;8(1):11635. doi: 10.1038/s41598-018-29952-z.

13.

Familial Ovarian Cancer Clusters with Other Cancers.

Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K.

Sci Rep. 2018 Aug 1;8(1):11561. doi: 10.1038/s41598-018-29888-4.

14.

Familial Associations in Testicular Cancer with Other Cancers.

Zhang L, Yu H, Hemminki O, Försti A, Sundquist K, Hemminki K.

Sci Rep. 2018 Jul 18;8(1):10880. doi: 10.1038/s41598-018-28819-7.

15.

Borderline Ovarian Tumors Share Familial Risks with Themselves and Invasive Cancers.

Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K.

Cancer Epidemiol Biomarkers Prev. 2018 Jul 17. doi: 10.1158/1055-9965.EPI-18-0503. [Epub ahead of print]

PMID:
30018148
16.

Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden.

Hemminki K, Hemminki O, Koskinen AIM, Försti A, Sundquist K, Sundquist J, Li X.

BMC Nephrol. 2018 Jul 3;19(1):158. doi: 10.1186/s12882-018-0945-y.

17.

Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.

Huhn S, da Silva Filho MI, Sanmuganantham T, Pichulik T, Catalano C, Pardini B, Naccarati A, Polakova-Vymetálkova V, Jiraskova K, Vodickova L, Vodicka P, Löffler MW, Courth L, Wehkamp J, Din FVN, Timofeeva M, Farrington SM, Jansen L, Hemminki K, Chang-Claude J, Brenner H, Hoffmeister M, Dunlop MG, Weber ANR, Försti A.

PLoS One. 2018 Jun 21;13(6):e0199350. doi: 10.1371/journal.pone.0199350. eCollection 2018.

18.

Oral diabetes medications other than dipeptidyl peptidase 4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study.

Varpuluoma O, Försti AK, Jokelainen J, Turpeinen M, Timonen M, Tasanen K, Huilaja L.

J Am Acad Dermatol. 2018 May 25. pii: S0190-9622(18)30826-0. doi: 10.1016/j.jaad.2018.05.030. [Epub ahead of print]

PMID:
29803903
19.

Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.

Catalano C, da Silva Filho MI, Jiraskova K, Vymetalkova V, Levy M, Liska V, Vycital O, Naccarati A, Vodickova L, Hemminki K, Vodicka P, Weber ANR, Försti A.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):838-842. doi: 10.1097/MEG.0000000000001154.

PMID:
29762254
20.

Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.

Bandapalli OR, Paramasivam N, Giangiobbe S, Kumar A, Benisch W, Engert A, Witzens-Harig M, Schlesner M, Hemminki K, Försti A.

Int J Cancer. 2018 Oct 15;143(8):2076-2078. doi: 10.1002/ijc.31576. Epub 2018 Jul 26. No abstract available.

PMID:
29708584
21.

Familial Risks Between Urolithiasis and Cancer.

Hemminki K, Hemminki O, Försti A, Sundquist J, Sundquist K, Li X.

Sci Rep. 2018 Feb 15;8(1):3083. doi: 10.1038/s41598-018-21410-0.

22.

Vildagliptin Significantly Increases the Risk of Bullous Pemphigoid: A Finnish Nationwide Registry Study.

Varpuluoma O, Försti AK, Jokelainen J, Turpeinen M, Timonen M, Huilaja L, Tasanen K.

J Invest Dermatol. 2018 Jul;138(7):1659-1661. doi: 10.1016/j.jid.2018.01.027. Epub 2018 Feb 7. No abstract available.

PMID:
29427585
23.

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels.

Yadav P, Merz M, Mai EK, Försti A, Jauch A, Goldschmidt H, Hemminki K.

Haematologica. 2018 Apr;103(4):e162-e164. doi: 10.3324/haematol.2017.184226. Epub 2018 Feb 1. No abstract available.

24.

Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.

Catalano C, da Silva Filho MI, Frank C, Jiraskova K, Vymetalkova V, Levy M, Liska V, Vycital O, Naccarati A, Vodickova L, Hemminki K, Vodicka P, Weber ANR, Försti A.

PLoS One. 2018 Feb 6;13(2):e0192385. doi: 10.1371/journal.pone.0192385. eCollection 2018.

25.

Familial risks for gallstones in the population of Sweden.

Hemminki K, Hemminki O, Försti A, Sundquist K, Sundquist J, Li X.

BMJ Open Gastroenterol. 2017 Dec 29;4(1):e000188. doi: 10.1136/bmjgast-2017-000188. eCollection 2017.

26.

Direct evidence for a polygenic etiology in familial multiple myeloma.

Halvarsson BM, Wihlborg AK, Ali M, Lemonakis K, Johnsson E, Niroula A, Cibulskis C, Weinhold N, Försti A, Alici E, Langer C, Pfreundschuh M, Goldschmidt H, Mellqvist UH, Turesson I, Waage A, Hemminki K, Golub T, Nahi H, Gullberg U, Hansson M, Nilsson B.

Blood Adv. 2017 Apr 7;1(10):619-623. doi: 10.1182/bloodadvances.2016003111. eCollection 2017 Apr 11.

27.

SNPs related to vitamin D and breast cancer risk: a case-control study.

Huss L, Butt ST, Almgren P, Borgquist S, Brandt J, Försti A, Melander O, Manjer J.

Breast Cancer Res. 2018 Jan 2;20(1):1. doi: 10.1186/s13058-017-0925-3.

28.

Familial risks in urolithiasis in the population of Sweden.

Hemminki K, Hemminki O, Försti A, Sundquist K, Sundquist J, Li X.

BJU Int. 2018 Mar;121(3):479-485. doi: 10.1111/bju.14096. Epub 2018 Jan 14.

PMID:
29235239
29.

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.

Sud A, Thomsen H, Law PJ, Försti A, Filho MIDS, Holroyd A, Broderick P, Orlando G, Lenive O, Wright L, Cooke R, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Hoffmann P, Nöthen MM, Jöckel KH, Strandmann EPV, Lightfoot T, Kane E, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS.

Nat Commun. 2017 Dec 1;8(1):1892. doi: 10.1038/s41467-017-00320-1.

30.

Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study.

Brandt J, Borgquist S, Almgren P, Försti A, Huss L, Melander O, Manjer J.

Int J Cancer. 2018 Apr 1;142(7):1309-1321. doi: 10.1002/ijc.31156. Epub 2017 Nov 29.

PMID:
29134650
31.

Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.

Barontini J, Antinucci M, Tofanelli S, Cammalleri M, Dal Monte M, Gemignani F, Vodicka P, Marangoni R, Vodickova L, Kupcinskas J, Vymetalkova V, Forsti A, Canzian F, Stein A, Moreno V, Mastrodonato N, Tavano F, Panza A, Barale R, Landi S, Campa D.

BMC Gastroenterol. 2017 Sep 15;17(1):104. doi: 10.1186/s12876-017-0659-9.

32.

Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism.

Li N, Johnson DC, Weinhold N, Kimber S, Dobbins SE, Mitchell JS, Kinnersley B, Sud A, Law PJ, Orlando G, Scales M, Wardell CP, Försti A, Hoang PH, Went M, Holroyd A, Hariri F, Pastinen T, Meissner T, Goldschmidt H, Hemminki K, Morgan GJ, Kaiser M, Houlston RS.

Cell Rep. 2017 Sep 12;20(11):2556-2564. doi: 10.1016/j.celrep.2017.08.062.

33.

Familial associations of male breast cancer with other cancers.

Zheng G, Yu H, Hemminki A, Försti A, Sundquist K, Hemminki K.

Breast Cancer Res Treat. 2017 Dec;166(3):897-902. doi: 10.1007/s10549-017-4468-1. Epub 2017 Aug 23.

PMID:
28836035
34.

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis.

Hemminki K, Hemminki O, Försti A, Sundquist K, Sundquist J, Li X.

Sci Rep. 2017 Aug 14;7(1):8073. doi: 10.1038/s41598-017-08839-5.

35.

Familial associations of female breast cancer with other cancers.

Zheng G, Yu H, Hemminki A, Försti A, Sundquist K, Hemminki K.

Int J Cancer. 2017 Dec 1;141(11):2253-2259. doi: 10.1002/ijc.30927. Epub 2017 Aug 26.

PMID:
28801919
36.

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

Meziane I, Huhn S, Filho MIDS, Weinhold N, Campo C, Nickel J, Hoffmann P, Nöthen MM, Jöckel KH, Landi S, Mitchell JS, Johnson D, Jauch A, Morgan GJ, Houlston R, Goldschmidt H, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Försti A, Schönland SO, Hemminki K.

Haematologica. 2017 Oct;102(10):e411-e414. doi: 10.3324/haematol.2017.171108. Epub 2017 Jul 4. No abstract available.

37.

Neurological and psychiatric associations in bullous pemphigoid-more than skin deep?

Försti AK, Huilaja L, Schmidt E, Tasanen K.

Exp Dermatol. 2017 Dec;26(12):1228-1234. doi: 10.1111/exd.13401. Epub 2017 Sep 24. Review.

PMID:
28677172
38.

Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach.

Went M, Sud A, Law PJ, Johnson DC, Weinhold N, Försti A, van Duin M, Mitchell JS, Chen B, Kuiper R, Stephens OW, Bertsch U, Campo C, Einsele H, Gregory WM, Henrion M, Hillengass J, Hoffmann P, Jackson GH, Lenive O, Nickel J, Nöthen MM, da Silva Filho MI, Thomsen H, Walker BA, Broyl A, Davies FE, Langer C, Hansson M, Kaiser M, Sonneveld P, Goldschmidt H, Hemminki K, Nilsson B, Morgan GJ, Houlston RS.

Blood Cancer J. 2017 Jun 16;7(6):e573. doi: 10.1038/bcj.2017.48. No abstract available.

39.

Genetics of gallbladder cancer.

Hemminki K, Hemminki A, Försti A, Sundquist K, Li X.

Lancet Oncol. 2017 Jun;18(6):e296. doi: 10.1016/S1470-2045(17)30324-8. No abstract available.

PMID:
28593851
40.

Inherited variants in genes somatically mutated in thyroid cancer.

Campo C, Köhler A, Figlioli G, Elisei R, Romei C, Cipollini M, Bambi F, Hemminki K, Gemignani F, Landi S, Försti A.

PLoS One. 2017 Apr 14;12(4):e0174995. doi: 10.1371/journal.pone.0174995. eCollection 2017. Erratum in: PLoS One. 2018 Aug 7;13(8):e0202208.

41.

Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).

Thomsen H, Campo C, Weinhold N, da Silva Filho MI, Pour L, Gregora E, Vodicka P, Vodickova L, Hoffmann P, Nöthen MM, Jöckel KH, Langer C, Hajek R, Goldschmidt H, Hemminki K, Försti A.

Eur J Haematol. 2017 Jul;99(1):70-79. doi: 10.1111/ejh.12892. Epub 2017 May 24.

PMID:
28375557
42.

Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.

Campo C, da Silva Filho MI, Weinhold N, Mahmoudpour SH, Goldschmidt H, Hemminki K, Merz M, Försti A.

Hematol Oncol. 2018 Feb;36(1):232-237. doi: 10.1002/hon.2391. Epub 2017 Mar 20.

PMID:
28317148
43.

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.

Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, Chen WV, Law MH, Bowdler LM, Iles MM, Yang Q, Worrall BB, Markus HS, Hung RJ, Amos CI, Spurdle AB, Thompson DJ, O'Mara TA, Wolpin B, Amundadottir L, Stolzenberg-Solomon R, Trichopoulou A, Onland-Moret NC, Lund E, Duell EJ, Canzian F, Severi G, Overvad K, Gunter MJ, Tumino R, Svenson U, van Rij A, Baas AF, Bown MJ, Samani NJ, van t'Hof FNG, Tromp G, Jones GT, Kuivaniemi H, Elmore JR, Johansson M, Mckay J, Scelo G, Carreras-Torres R, Gaborieau V, Brennan P, Bracci PM, Neale RE, Olson SH, Gallinger S, Li D, Petersen GM, Risch HA, Klein AP, Han J, Abnet CC, Freedman ND, Taylor PR, Maris JM, Aben KK, Kiemeney LA, Vermeulen SH, Wiencke JK, Walsh KM, Wrensch M, Rice T, Turnbull C, Litchfield K, Paternoster L, Standl M, Abecasis GR, SanGiovanni JP, Li Y, Mijatovic V, Sapkota Y, Low SK, Zondervan KT, Montgomery GW, Nyholt DR, van Heel DA, Hunt K, Arking DE, Ashar FN, Sotoodehnia N, Woo D, Rosand J, Comeau ME, Brown WM, Silverman EK, Hokanson JE, Cho MH, Hui J, Ferreira MA, Thompson PJ, Morrison AC, Felix JF, Smith NL, Christiano AM, Petukhova L, Betz RC, Fan X, Zhang X, Zhu C, Langefeld CD, Thompson SD, Wang F, Lin X, Schwartz DA, Fingerlin T, Rotter JI, Cotch MF, Jensen RA, Munz M, Dommisch H, Schaefer AS, Han F, Ollila HM, Hillary RP, Albagha O, Ralston SH, Zeng C, Zheng W, Shu XO, Reis A, Uebe S, Hüffmeier U, Kawamura Y, Otowa T, Sasaki T, Hibberd ML, Davila S, Xie G, Siminovitch K, Bei JX, Zeng YX, Försti A, Chen B, Landi S, Franke A, Fischer A, Ellinghaus D, Flores C, Noth I, Ma SF, Foo JN, Liu J, Kim JW, Cox DG, Delattre O, Mirabeau O, Skibola CF, Tang CS, Garcia-Barcelo M, Chang KP, Su WH, Chang YS, Martin NG, Gordon S, Wade TD, Lee C, Kubo M, Cha PC, Nakamura Y, Levy D, Kimura M, Hwang SJ, Hunt S, Spector T, Soranzo N, Manichaikul AW, Barr RG, Kahali B, Speliotes E, Yerges-Armstrong LM, Cheng CY, Jonas JB, Wong TY, Fogh I, Lin K, Powell JF, Rice K, Relton CL, Martin RM, Davey Smith G.

JAMA Oncol. 2017 May 1;3(5):636-651. doi: 10.1001/jamaoncol.2016.5945.

44.

Functional germline variants in driver genes of breast cancer.

Göhler S, Da Silva Filho MI, Johansson R, Enquist-Olsson K, Henriksson R, Hemminki K, Lenner P, Försti A.

Cancer Causes Control. 2017 Apr;28(4):259-271. doi: 10.1007/s10552-017-0849-3. Epub 2017 Feb 25.

PMID:
28238063
45.

Familial associations of lymphoma and myeloma with autoimmune diseases.

Hemminki K, Försti A, Sundquist K, Sundquist J, Li X.

Blood Cancer J. 2017 Jan 6;7(1):e515. doi: 10.1038/bcj.2016.123.

46.

Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Law PJ, Sud A, Mitchell JS, Henrion M, Orlando G, Lenive O, Broderick P, Speedy HE, Johnson DC, Kaiser M, Weinhold N, Cooke R, Sunter NJ, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Carmichael J, Bailey JR, Pratt G, Rahman T, Pepper C, Fegan C, von Strandmann EP, Engert A, Försti A, Chen B, Filho MI, Thomsen H, Hoffmann P, Noethen MM, Eisele L, Jöckel KH, Allan JM, Swerdlow AJ, Goldschmidt H, Catovsky D, Morgan GJ, Hemminki K, Houlston RS.

Sci Rep. 2017 Jan 23;7:41071. doi: 10.1038/srep41071.

47.

Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

da Silva Filho MI, Försti A, Weinhold N, Meziane I, Campo C, Huhn S, Nickel J, Hoffmann P, Nöthen MM, Jöckel KH, Landi S, Mitchell JS, Johnson D, Morgan GJ, Houlston R, Goldschmidt H, Jauch A, Milani P, Merlini G, Rowcieno D, Hawkins P, Hegenbart U, Palladini G, Wechalekar A, Schönland SO, Hemminki K.

Leukemia. 2017 Aug;31(8):1735-1742. doi: 10.1038/leu.2016.387. Epub 2016 Dec 27.

PMID:
28025584
48.

Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.

Försti AK, Jokelainen J, Ansakorpi H, Seppänen A, Majamaa K, Timonen M, Tasanen K.

Sci Rep. 2016 Nov 15;6:37125. doi: 10.1038/srep37125.

49.

Identification of miRSNPs associated with the risk of multiple myeloma.

Macauda A, Calvetti D, Maccari G, Hemminki K, Försti A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martinez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudziński M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jażdżewska E, Raźny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stępień A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet-Loiseau H, Lesueur F, Grząśko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F.

Int J Cancer. 2017 Feb 1;140(3):526-534. doi: 10.1002/ijc.30465. Epub 2016 Nov 9.

50.

A review of the infection-associated cancers in North African countries.

Hussein WM, Anwar WA, Attaleb M, Mazini L, Försti A, Trimbitas RD, Khyatti M.

Infect Agent Cancer. 2016 Aug 10;11:35. doi: 10.1186/s13027-016-0083-8. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center